AGTC Announces Departure of Chief Scientific Officer
April 26, 2021 16:02 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
AGTC licenses Promoter Technology to SparingVision SAS
April 19, 2021 07:00 ET
|
Applied Genetic Technologies Corporation
-Technology To Be Incorporated In Multiple SparingVision SAS Programs- ALACHUA, Fla. and CAMBRIDGE, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:...
TeamedOn and AGTC Announce a Licensing Agreement Advancing X-Linked Retinoschisis Gene Therapy Program
April 13, 2021 07:00 ET
|
Applied Genetic Technologies Corporation; TeamedOn International, Inc.
- AGTC Transfers Clinical Trial Materials and Phase 1/2 Data To TeamedON - ROCKVILLE, Md., April 13, 2021 (GLOBE NEWSWIRE) -- TeamedOn International, Inc., a biotechnology company dedicated to...
AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and Cell and Gene Conference
March 31, 2021 08:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
AGTC Announces New Initiatives To Enhance The Patient Journey In Its XLRP Trials
March 25, 2021 07:00 ET
|
Applied Genetic Technologies Corporation
-AGTC’s deep commitment to the patient voice drives solutions to support patient access to information and to improve the experience of patients participating in clinical trials- GAINESVILLE, Fla.,...
AGTC to Present at the Gene Therapy Patient Engagement Summit, Held Virtually, March 24, 2021
March 18, 2021 12:00 ET
|
Applied Genetic Technologies Corporation
-AGTC will highlight the value of the patient voice in gene therapy development- GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation...
AGTC to Present at Upcoming Investor Conferences
March 02, 2021 07:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
AGTC to Present at the OIS Gene Therapy Innovation Showcase on February 18, 2021
February 16, 2021 12:00 ET
|
Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
AGTC to Present at the 4th Annual Gene Therapy for Rare Disorders Digital Event, February 22-25, 2021
February 16, 2021 08:00 ET
|
Applied Genetic Technologies Corporation
-AGTC executives will address critical success factors in gene therapy manufacturing and the value of the patient perspective in gene therapy development ---- GAINESVILLE, Fla. and CAMBRIDGE,...
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2020
February 11, 2021 07:00 ET
|
Applied Genetic Technologies Corporation
- Company on track to provide multiple data readouts for XLRP and ACHM clinical programs in 2021 and 2022 - - Net proceeds of approximately $69.2 million from a recent public offering provide cash...